Evidence map›Paper›PMID 22191803›Full record

ArticleJournal of neurochemistry2012

Mephedrone, an abused psychoactive component of 'bath salts' and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum.

Mariana Angoa-Pérez, Michael J Kane, Dina M Francescutti, Katherine E Sykes, Mrudang M Shah, Abiy M Mohammed, David M Thomas, Donald M Kuhn

Abstract read
In one paragraph

Article in Journal of neurochemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. An updated review on synthetic cathinones.Archives of toxicology · 2021
    Review
  11. Article
  12. Review
  13. Article
  14. Psychoactive Bath Salts and Neurotoxicity Risk.Turkish journal of pharmaceutical sciences · 2020
    Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mariana Angoa-PérezDepartment of Psychiatry & Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, Michigan, USA.
Michael J Kane
Dina M Francescutti
Katherine E Sykes
Mrudang M Shah
Abiy M Mohammed
David M Thomas
Donald M Kuhn

Funding

NEUROTOXIC AMPHETAMINES RADICALS AND 5HT NEURONSR01DA010756 · NIDA · WAYNE STATE UNIVERSITY · PI KUHN, DONALD M · 1997 to 2011
$3.1M
Methamphetamine Neurotoxity and Microglial ActivationR01DA017327 · NIDA · WAYNE STATE UNIVERSITY · PI KUHN, DONALD M · 2005 to 2009
$1.3M
Role of TPH2 and 5HT Neuronal Loss in Non-motor Symptoms of Parkinson'sI01RX000458 · VA · JOHN D DINGELL VA MEDICAL CENTER · PI KUHN, DONALD M · 2012 to 2020
–
NIDA NIH HHS R01 DA010756NIDA NIH HHS R01 DA017327RRD VA I01 RX000458
6 · The paper itself

Abstract

Mephedrone (4-methylmethcathinone) is a β-ketoamphetamine with close structural analogy to substituted amphetamines and cathinone derivatives. Abuse of mephedrone has increased dramatically in recent years and has become a significant public health problem in the United States and Europe. Unfortunately, very little information is available on the pharmacological and neurochemical actions of mephedrone. In light of the proven abuse potential of mephedrone and considering its similarity to methamphetamine and methcathinone, it is particularly important to know if mephedrone shares with these agents an ability to cause damage to dopamine nerve endings of the striatum. Accordingly, we treated mice with a binge-like regimen of mephedrone (4 × 20 or 40 mg/kg) and examined the striatum for evidence of neurotoxicity 2 or 7 days after treatment. While mephedrone caused hyperthermia and locomotor stimulation, it did not lower striatal levels of dopamine, tyrosine hydroxylase or the dopamine transporter under any of the treatment conditions used presently. Furthermore, mephedrone did not cause microglial activation in striatum nor did it increase glial fibrillary acidic protein levels. Taken together, these surprising results suggest that mephedrone, despite its numerous mechanistic overlaps with methamphetamine and the cathinone derivatives, does not cause neurotoxicity to dopamine nerve endings of the striatum.

Indexed as

AnimalsBehavior, AnimalBody TemperatureCentral Nervous System StimulantsCorpus StriatumDopamineDopamine Plasma Membrane Transport ProteinsDopaminergic NeuronsFemaleMethamphetamineMiceMice, Inbred C57BLNerve EndingsNeurogliaTyrosine 3-MonooxygenaseCentral Nervous System StimulantsDopamineDopamine Plasma Membrane Transport ProteinsmephedroneMethamphetamineTyrosine 3-Monooxygenase

Identifiers

PMID22191803
PMCPMC3296829

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.